1U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: Recommendation statement[J]. Ann Intern Med.2005,142:198-202.
2Isselbacher EM. Diseases of the aorta[A]. In: Zipes DP,Libby P, Bonow RO, et al . ed. Braunwald's heart disease:A textbook of cardiovascular medicine. 7th ed[M]. Philadelphia: Elsevier Saunders, 2005. 1403-1435.
3Lederle FA, Johnson GR, Wilson SE, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators[J]. Arch Intern Med,2000,160:1425-1430.
4Hirsch AT. Haskal ZJ. Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric,and abdominal aortic) [J]. Circulation. 2006, 113: e463-e634.
8Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms[J]. J Clin Invest,2002,110:625-632.
10David CB, Jack LC, John WH. Guidelines for the treatment of abdominal aortic aneurysms: Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery[J]. J Vasc Surg,2003.37: 1106-1117.
2Maggiano N, Larocca LM, Pinntelli M, et al. Detection of mRNA and hnRNA using a digoxigenin labeled cDNA probe by in situ hybridization on frozen tissue sections [J]. Histochem J, 1991, 23(19): 69-74.
3Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrixmetalloproteinases during aneurysm formation [J].Nat Genet, 1997, 17(11): 439-44.
4Shah PK. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm [J]. Circulation, 1997, 96(9): 2115-7.
5Thompson RW, Parks WC. Role of matrix meralloproteinases in abdominal aortic aneurysms [J]. Ann N Y Acad Sci, 1996, 800(11):157-74.
6Migntti P. Extracellular matrix remodeling by metallopro teinases abd okasminogen activators [J]. Kidney Int, 1995, 47(Suppl 49):12-4.
7Roldan AL, Cubellis MV, Masucci MT, et al. Cloning and expression of the receptor for humanurokonase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis [J].EMBO J, 1999, 16(21): 467-74.
8Vassali JD, Baccino D, Belin D, et al. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinaes [ J ].J Cell Biol, 1985, 100(12): 86-92.
9Ellis V, Behrendt N, Dano K, et al. Plasminogen activation by receptor-bound urokinase, a kinetic study with both cell-associated and isolated receptor[ J]. J Biol Chem, 1991, 266: 12752-8.
10Anidjar S, Salzmann JL, Gentric D, et al. Elastase induces experimentalaneurysms in rats [J]. Circulation, 2001, 82 (14):973-81.
4Maeda H,Umezawa H,Goshima M. Primary infected abdominal aortic aneurysm:surgical procedures,early mortality rates,and a survey of the prevalence of infectious organisms over a 30-year period[J].Surgery Today(Japanese Journal of Surgery ),2011,(03):346-351.
6Baskaran D, Ashr',ff N, Abroad A, et al. Inflammatory. abdominal aortic aneurysm: a persistent painful hip[ J]. BMJ Case Rep, :-013, pii: bcr2013009150.
7Boontje AH, van den Dungen abdominal aortic aneurysms [ J ] 1990, 31(5) :611-616.
8J J, Blanksma C. Inflammatory J Cardiovasc Surg (Torino), Stella A, Gargiulo M, Faggioli GI,, et al. Postoperative course of inflammatory abdominal aortic aneurysms [ J ]. Ann Vasc Surg, 1993, 7(3 ) :229-238.
9Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chrunie periaortitis: a prospective study[ J]. Am J Med, 2003, 114(6) :454-462.
10Frego M, Bianehera G, Angriman I,, el al. Ruptured aneurysms of the abdominal aorta: from the First Aid to the Operating Room. Changing concepts [J]. Ann ltal Chit, 2007, 78(4):277-281.
